Published in Infect Immun on June 28, 2010
Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages. Infect Immun (2012) 0.93
Rapid divergence of two classes of Haemophilus ducreyi. J Bacteriol (2011) 0.84
Mutational analysis of hemoglobin binding and heme utilization by a bacterial hemoglobin receptor. J Bacteriol (2013) 0.78
A vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types. PLoS One (2014) 0.78
Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid. Infect Immun (2011) 0.77
Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA. Monoclon Antib Immunodiagn Immunother (2015) 0.75
The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin. Sci Rep (2017) 0.75
Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis (1992) 10.85
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (2004) 8.09
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05
Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med (2002) 6.23
Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science (1998) 5.62
Crystal structure of the outer membrane active transporter FepA from Escherichia coli. Nat Struct Biol (1999) 4.86
Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin Microbiol (1978) 4.20
Structural basis of gating by the outer membrane transporter FecA. Science (2002) 3.40
Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell (1998) 3.27
Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun (1991) 3.11
Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine (1998) 2.74
Antigenicity of Neisseria gonorrhoeae outer membrane protein(s) III detected by immunoprecipitation and Western blot transfer with a monoclonal antibody. Infect Immun (1982) 2.48
Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis (1989) 2.41
Substrate-induced transmembrane signaling in the cobalamin transporter BtuB. Nat Struct Biol (2003) 2.41
Detection of antibody-accessible proteins on the cell surface of Haemophilus influenzae type b. Infect Immun (1981) 2.41
Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci (2008) 2.39
Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev (1995) 2.30
Experimental human infection with Haemophilus ducreyi. J Infect Dis (1994) 2.30
Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity. J Exp Med (1990) 2.29
Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis (1998) 2.12
Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis (1996) 2.12
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis (1998) 2.00
Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis (1995) 1.83
Identification and purification of a conserved heme-regulated hemoglobin-binding outer membrane protein from Haemophilus ducreyi. Infect Immun (1995) 1.77
An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection. J Infect Dis (2000) 1.69
Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol Microbiol (1992) 1.66
The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg (1995) 1.58
Eradicating chancroid. Bull World Health Organ (2001) 1.56
Diversity of siderophore-mediated iron uptake systems in fluorescent pseudomonads: not only pyoverdines. Environ Microbiol (2002) 1.53
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine (2008) 1.43
Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine (2009) 1.39
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int (2005) 1.35
Characterization of the diversity and the transferrin-binding domain of gonococcal transferrin-binding protein 2. Infect Immun (1997) 1.34
Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants. Microb Pathog (1999) 1.31
Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Infect Immun (1985) 1.27
A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy (2001) 1.24
Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations. Infect Immun (2005) 1.23
Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid. Infect Immun (1999) 1.22
New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev Vaccines (2007) 1.19
Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins. Infect Immun (2003) 1.14
Clinical and microbiologic studies of genital ulcers in Kenyan women. Sex Transm Dis (1986) 1.14
An immunohistochemical analysis of naturally occurring chancroid. J Infect Dis (1996) 1.09
Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line. Infect Immun (2001) 1.08
The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1. Vaccine (1999) 1.06
Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence. Infect Immun (1998) 1.05
Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. J Infect Dis (1996) 1.05
Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Infect Immun (2006) 1.03
Chancroid and Haemophilus ducreyi. Ann Intern Med (1985) 0.99
Development of a serological test for Haemophilus ducreyi for seroprevalence studies. J Clin Microbiol (2000) 0.99
Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi. Microb Pathog (1995) 0.98
In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes. Infect Immun (2002) 0.97
Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant. Regul Toxicol Pharmacol (2002) 0.96
Evaluation of the repertoire of the TonB-dependent receptors of Haemophilus ducreyi for their role in virulence in humans. J Infect Dis (2008) 0.94
Proposed second class of Haemophilus ducreyi strains show altered protein and lipooligosaccharide profiles. Proteomics (2007) 0.94
Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi. Infect Immun (2006) 0.91
Preclinical development of AS04. Methods Mol Biol (2010) 0.87
Proteome of Haemophilus ducreyi by 2-D SDS-PAGE and mass spectrometry: strain variation, virulence, and carbohydrate expression. J Proteome Res (2003) 0.87
An immunogenic, surface-exposed domain of Haemophilus ducreyi outer membrane protein HgbA is involved in hemoglobin binding. Infect Immun (2009) 0.87
An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits. Lab Anim Sci (1991) 0.85
Pollinex Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL) for the treatment of ragweed pollen allergy. J Appl Toxicol (2007) 0.84
Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi. Microb Pathog (1998) 0.84
A humoral immune response confers protection against Haemophilus ducreyi infection. Infect Immun (2003) 0.84
Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF. Vaccine (2002) 0.82
Comparison of antibody response by use of synthetic adjuvant system and Freund complete adjuvant in rabbits. Am J Vet Res (1991) 0.78
Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA (2004) 5.66
Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis (2006) 3.17
Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis (2007) 2.85
Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57
The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis (2005) 2.31
Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Transm Dis (2006) 2.31
Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health (2006) 2.17
Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol (2002) 1.58
Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol (2011) 1.56
Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis (2004) 1.54
Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis (2003) 1.52
Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol (2005) 1.40
Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men. J Clin Microbiol (2003) 1.34
Biological markers of sexual activity: tools for improving measurement in HIV/sexually transmitted infection prevention research. Sex Transm Dis (2013) 1.24
Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations. Infect Immun (2005) 1.23
Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis (2011) 1.22
Randomised controlled trial on whether advance knowledge of prostate-specific antigen testing improves participant reporting of unprotected sex. Sex Transm Infect (2006) 1.19
Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis (2008) 1.17
Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol (2006) 1.12
The Haemophilus ducreyi serum resistance antigen DsrA confers attachment to human keratinocytes. Infect Immun (2002) 1.12
Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology (2010) 1.12
Unexpected similarities between Bordetella avium and other pathogenic Bordetellae. Infect Immun (2003) 1.10
Chlamydia trachomatis infection among 15- to 35-year-olds in Baltimore, MD. Sex Transm Dis (2011) 1.10
Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis (2012) 1.10
Opposing selective forces for expression of the gonococcal lactoferrin receptor. Mol Microbiol (2003) 1.10
Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis. J Immunol (2013) 1.06
Genetic typing of the porin protein of Neisseria gonorrhoeae from clinical noncultured samples for strain characterization and identification of mixed gonococcal infections. J Clin Microbiol (2005) 1.06
BhuR, a virulence-associated outer membrane protein of Bordetella avium, is required for the acquisition of iron from heme and hemoproteins. Infect Immun (2002) 1.05
Self-reported condom use is associated with reduced risk of chlamydia, gonorrhea, and trichomoniasis. Sex Transm Dis (2007) 1.05
The association between Trichomonas vaginalis infection and level of vaginal lactobacilli, in nonpregnant women. J Infect Dis (2007) 1.04
Influence of pregnancy on the pathogenesis of listeriosis in mice inoculated intragastrically. Infect Immun (2003) 1.04
Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Infect Immun (2006) 1.03
A novel lectin, DltA, is required for expression of a full serum resistance phenotype in Haemophilus ducreyi. Infect Immun (2004) 1.02
Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding. Infect Immun (2005) 1.02
Heparin modifies the immunogenicity of positively charged proteins. Blood (2010) 1.00
Localization of the domains of the Haemophilus ducreyi trimeric autotransporter DsrA involved in serum resistance and binding to the extracellular matrix proteins fibronectin and vitronectin. Infect Immun (2008) 0.98
B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis. J Immunol (2011) 0.97
Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid. Infect Immun (2006) 0.97
A DltA mutant of Haemophilus ducreyi Is partially attenuated in its ability to cause pustules in human volunteers. Infect Immun (2006) 0.96
Predictors of unprotected sex among female sex workers in Madagascar: comparing semen biomarkers and self-reported data. AIDS Behav (2010) 0.95
Evaluation of the repertoire of the TonB-dependent receptors of Haemophilus ducreyi for their role in virulence in humans. J Infect Dis (2008) 0.94
The Product of the fimI gene is necessary for Escherichia coli type 1 pilus biosynthesis. J Bacteriol (2003) 0.94
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.94
Engineering a ubiquitin ligase reveals conformational flexibility required for ubiquitin transfer. J Biol Chem (2009) 0.94
Influence of extracellular bactericidal agents on bacteria within macrophages. Infect Immun (2003) 0.93
Immunogenicity of gonococcal transferrin binding proteins during natural infections. Infect Immun (2004) 0.93
A Listeria monocytogenes mutant defective in bacteriophage attachment is attenuated in orally inoculated mice and impaired in enterocyte intracellular growth. Infect Immun (2008) 0.91
A novel mechanism of complement inhibition unmasked by a tick salivary protein that binds to properdin. J Immunol (2008) 0.90
The use of specimens from various genitourinary sites in men, to detect Trichomonas vaginalis infection. J Infect Dis (2004) 0.90
Quantitative glycomics from fluidic glycan microarrays. J Am Chem Soc (2009) 0.90
Neisseria gonorrhoeae suppresses dendritic cell-induced, antigen-dependent CD4 T cell proliferation. PLoS One (2012) 0.90
Development of a rapid immunodiagnostic test for Haemophilus ducreyi. J Clin Microbiol (2002) 0.89
Outer membrane protein DsrA is the major fibronectin-binding determinant of Haemophilus ducreyi. Infect Immun (2008) 0.89
Improving the accuracy of syndromic diagnosis of genital ulcer disease in Malawi. Sex Transm Dis (2005) 0.87
Adaptation in a mouse colony monoassociated with Escherichia coli K-12 for more than 1,000 days. Appl Environ Microbiol (2010) 0.87
An immunogenic, surface-exposed domain of Haemophilus ducreyi outer membrane protein HgbA is involved in hemoglobin binding. Infect Immun (2009) 0.87
Use of bacteriophage Ba1 to identify properties associated with Bordetella avium virulence. Infect Immun (2002) 0.86
Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors. Sex Transm Dis (2012) 0.85
Identification and characterization of two Bordetella avium gene products required for hemagglutination. Infect Immun (2010) 0.84
A humoral immune response confers protection against Haemophilus ducreyi infection. Infect Immun (2003) 0.84
Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi. Infect Immun (2013) 0.81
Identification and preliminary characterization of a 75-kDa hemin- and hemoglobin-binding outer membrane protein of Actinobacillus pleuropneumoniae serotype 1. Can J Vet Res (2003) 0.80
Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. J Immunol Methods (2005) 0.79
Altering and assessing persistence of genetically modified E. coli MG1655 in the large bowel. Exp Biol Med (Maywood) (2009) 0.79
In vitro properties of a Listeria monocytogenes bacteriophage-resistant mutant predict its efficacy as a live oral vaccine strain. Infect Immun (2011) 0.79
Differences in misreporting of sexual behavior over time: implications for HIV trials. Sex Transm Dis (2015) 0.79
Genomic correlates of variability in immune response to an oral cholera vaccine. Eur J Hum Genet (2012) 0.78
Evaluation of peripheral lymphocytes after weaning and vaccination for Mycoplasma hyopneumoniae. Res Vet Sci (2010) 0.78
Factors associated with the acquisition and severity of gestational listeriosis. PLoS One (2010) 0.78
The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis. Sex Transm Dis (2009) 0.78
Does a choice of condoms impact sexually transmitted infection incidence? A randomized, controlled trial. Sex Transm Dis (2006) 0.78
Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid. Infect Immun (2011) 0.77
Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Expert Rev Anti Infect Ther (2014) 0.77
Prostate-specific antigen is unlikely to be a suitable biomarker of semen exposure from recent unprotected receptive anal intercourse in men who have sex with men. Sex Transm Dis (2014) 0.77
Biocompatibility analysis of an electrically-activated silver-based antibacterial surface system for medical device applications. J Mater Sci Mater Med (2012) 0.76
Borderline Personality Disorder Symptom Severity and Sexually Transmitted Infection and HIV Risk in African American Incarcerated Men. Sex Transm Dis (2016) 0.75
Extrauterine listeriosis in the gravid mouse influences embryonic growth and development. PLoS One (2013) 0.75
Incorporation of secretory immunoglobulin A into biofilms can decrease their resistance to ciprofloxacin. Microbiol Immunol (2011) 0.75
Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA. Monoclon Antib Immunodiagn Immunother (2015) 0.75
Quantification of Chlamydia trachomatis elementary bodies in urine by ligase chain reaction. J Clin Microbiol (2002) 0.75
Optimizing lavage during knee arthroscopy: a three-dimensional MRI study. J Magn Reson Imaging (2012) 0.75
Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets. Pharm Res (2014) 0.75